Resurgent Financial Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Resurgent Financial Advisors’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$583K	Buy	10,931 +1,608	+17%	+$94.4K	0.21%	117
2025 Q4	$579K	Buy	9,323 +2,706	+41%	+$167K	0.29%	99
2025 Q3	$398K	Buy	+6,617	New	+$405K	0.2%	144
2024 Q1	–	Sell	-704	Closed	-$38K	–	330
2023 Q4	$38K	Sell	704 -20	-3%	-$977	0.02%	383
2023 Q3	$35.1K	Hold	724	–	–	0.02%	385
2023 Q2	$40.9K	Hold	724	–	–	0.03%	362
2023 Q1	$39.1K	Sell	724 -71	-9%	-$3.78K	0.03%	375
2022 Q4	$41.8K	Buy	+795	New	+$40.3K	0.02%	465

Other funds holding IHI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Resurgent Financial Advisors's IHI Position: Q1 2026 in Review

Resurgent Financial Advisors increased its iShares US Medical Devices ETF (IHI) stake by 17% in Q1 2026, buying an estimated $94.4K and bringing the position to 10,931 shares worth $583K. The position accounts for 0.21% of the portfolio, ranked #117.

Resurgent Financial Advisors first reported a position in IHI in Q4 2022 and has held it in 8 quarters since. 503 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

Resurgent Financial Advisors held 10,931 shares of iShares US Medical Devices ETF worth $583K as of Q1 2026.
Resurgent Financial Advisors bought 1,608 iShares US Medical Devices ETF shares in Q1 2026, an estimated $94.4K.
iShares US Medical Devices ETF made up 0.21% of Resurgent Financial Advisors's portfolio in Q1 2026, its #117 holding.
Resurgent Financial Advisors first reported a position in iShares US Medical Devices ETF in Q4 2022 and has held it in 8 quarters since.
503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Resurgent Financial Advisors's 13F filing for Q1 2026, filed 13 May 2026.